Cancer Detection & Screening
Showing all 8 results
-
AFP (ALPHA-FETOPROTEIN TUMOR MARKER)
More InfoElevated AFP levels are found in the majority of patients with hepatocellular carcinoma and non-seminomatous testicular carcinoma.
-
Bilirubin, Direct
More InfoElevations of direct (conjugated) bilirubin are typically the result of an obstruction within the liver or a source outside the liver; for example, gallstones or a tumor blocking the bile ducts.
-
CA 15-3
More InfoCA 15-3 may be useful in monitoring response to therapy in patients with metastatic breast cancer. A majority of patients with a CA 15-3 increase of greater than 25% have disease progression.
-
CA 19-9
More InfoCA 19-9 is useful for monitoring colorectal, gastrointestinal, liver, and pancreatic malignancies.
-
CA 27.29
More InfoThis test is a tumor marker that is useful in the management of patients with metastatic carcinoma of the breast.
-
CA-125
More InfoUsed to detect ovarian cancer. CA-125 is elevated in the majority of women with carcinoma of the ovary.
-
CEA (Carcinoembryonic Antigen)
More InfoElevated CEA levels are seen in cancers of the breast, colon, lung, pancreas, rectum, and stomach.
-
HCG (Testicular Tumor)
More InfoHCG levels can be elevated with pathologic conditions such as testicular neoplasm, choriocarcinoma, and hydatiform mole.